Take a closer look at London's biotech hub – renowned for its thriving life sciences ecosystem and world-class infrastructure ...

AstraZeneca continues to impress me with the strong performances of its oncology, cardiovascular, and rare disease franchises ...

The Cambridge Biomedical Campus – already the largest centre of medical research and health science in Europe – could double ...

Cambridge, England-based biopharmaceutical giant AstraZeneca is pouring billions ... Its North American headquarters is located in Wilmington, Delaware. We're not asking for your money.

including its former headquarters in Cambridge. About 800 workers have moved into the 630,000-square-foot building, which is kitty-corner from the Boston Convention and Exhibition Center ...

AstraZeneca’s UK headquarters in Cambridge. Astrazeneca is to invest £650m in the UK, Chancellor Jeremy Hunt has announced in his Spring Budget. The pharmaceuticals giant will expand its ...

Multinational pharmaceutical company AstraZeneca said on Monday that Shanghai ... Following the four strategic centers in the UK's Cambridge, Boston and Gaithersburg in the United States, and ...

An AstraZeneca facility in Cambridge, including its headquarters, was first unveiled in 2013 and was project-managed by Skanska and then Mace. Its cost trebled from £330m to £1bn. Maria Eagle ...

AstraZeneca boss Sir Pascal Soriot ... a rocky start in 2013 when his decision to move its headquarters from Alderley Park in Cheshire to Cambridge, was branded by unions as a 'massive blow ...

AstraZeneca built its global R&D centre and corporate headquarters at the Cambridge Biomedical Campus with a $1.3bn investment. AstraZeneca’s Discovery Centre was inaugurated in November 2021. Credit: ...

The headquarters adopt sustainability standards that demonstrate ... and Vaccines & Infectious Diseases. Based in Cambridge, UK, AstraZeneca operates in over 100 countries, and its innovative ...

AstraZeneca’s Discovery Centre courtyard. Picture: David Porter. The company also unveiled plans for a new research and development site in Cambridge, Massachusetts, to be completed in 2026 that will ...